Drug Shortage Report for PRIVA-GABAPENTIN
| Report ID | 100895 |
| Drug Identification Number | 02450100 |
| Brand name | PRIVA-GABAPENTIN |
| Common or Proper name | GABAPENTIN |
| Company Name | PHARMAPAR INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | GABAPENTIN |
| Strength(s) | 300MG |
| Dosage form(s) | CAPSULE |
| Route of administration | ORAL |
| Packaging size | 100 |
| ATC code | N03AX |
| ATC description | ANTIEPILEPTICS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2019-12-09 |
| Estimated end date | 2020-03-16 |
| Actual end date | 2020-03-11 |
| Shortage status | Resolved |
| Updated date | 2020-03-12 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1565 BOUL LIONEL-BOULET VARENNES, QUEBEC CANADA J3X 1P7 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v9 | 2020-03-12 | English | Compare |
| v8 | 2020-03-11 | French | Compare |
| v7 | 2020-03-11 | English | Compare |
| v6 | 2020-02-26 | French | Compare |
| v5 | 2020-02-26 | English | Compare |
| v4 | 2020-01-20 | French | Compare |
| v3 | 2020-01-20 | English | Compare |
| v2 | 2019-12-10 | French | Compare |
| v1 | 2019-12-10 | English | Compare |
Showing 1 to 9 of 9